Form D · Other Technology
DexMat, Inc.
Houston, TX · CIK 0002104722
Offering snapshot reported Aug 19, 2026 · SEC filing
- Reported sold
- $1.05M Offering amount: $10M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 3, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 19, 2026 | Initial | $1,049,984 | No comparison | 2 | SEC filing |
| Feb 4, 2026 | Initial | $9,195,259 | No comparison | 79 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594774
Source: Form D, filed Aug 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jill Dupre | Executive |
| Bryan Guido Hassin | Director, Executive |
| Asena Hertz | Executive |
| Kent Lucas | Director |
| Matteo Pasquali | Director |
| Dmitri Tsentalovich | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
3333 Hwy 6 S, Bldg So, Ste 145/155
Houston, TX, 77082
Houston, TX, 77082